This inventor holds 13 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Baxter International Inc., Baxter Healthcare Sa. Active years: 2003-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gurnee, IL (US) (2003 - 2009)
- Long Grove, IL (US) (2012)
- Williamsville, NY (US) (2020 - 2023)
Company Filing History:
13 out of 2,533 
4 out of 1,201 Years Active: 2003-2023
Title: Joseph Chung Tak Wong: Innovator in Insulin Formulations
Introduction
Joseph Chung Tak Wong is an accomplished inventor based in Gurnee, IL, holding an impressive total of 13 patents. His work focuses primarily on the development of pharmaceutical formulations, particularly in the field of insulin premixes, which are crucial for individuals with metabolic disorders.
Latest Patents
One of Joseph's latest patents revolves around an innovative insulin premix formulation and its related methods. This formulation includes approximately 0.1-10.0 Unit/mL of insulin for intravenous administration, often supplemented with a tonicity adjuster. The patent details methods for preparing and utilizing this formulation, which can be aseptically filled into flexible container assemblies. The resulting product is a sterile, ready-to-use aqueous solution ideal for glycemic control via intravenous infusion. Remarkably, this insulin premix is stable when stored in refrigeration at temperatures between 2°C to 5°C for a duration of 24 months, followed by an additional 30 days at room temperature, without requiring any added preservatives, zinc, surfactants, or stabilizing excipients.
Career Highlights
Joseph Chung Tak Wong has significantly contributed to the pharmaceutical industry through his roles at notable companies like Baxter International Inc. and Baxter Healthcare SA. His innovative work has transformed how insulin is prepared and administered, ensuring better stability and efficacy for patients.
Collaborations
Throughout his career, Joseph has collaborated with talented individuals, including esteemed coworkers such as James E. Kipp and Mark Joseph Doty. These collaborations have paved the way for groundbreaking advancements in insulin formulations, demonstrating the importance of teamwork in the field of pharmaceutical innovation.
Conclusion
Joseph Chung Tak Wong's contributions to the development of stable insulin premix formulations mark an important milestone in the medical field. With 13 patents to his name, his ongoing efforts continue to improve the quality of care for individuals with metabolic disorders. His innovative spirit and collaborative approach exemplify the essence of progress in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile